1. Home
  2. EOLS vs KELYA Comparison

EOLS vs KELYA Comparison

Compare EOLS & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • KELYA
  • Stock Information
  • Founded
  • EOLS 2012
  • KELYA 1946
  • Country
  • EOLS United States
  • KELYA United States
  • Employees
  • EOLS N/A
  • KELYA N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • KELYA Professional Services
  • Sector
  • EOLS Health Care
  • KELYA Consumer Discretionary
  • Exchange
  • EOLS Nasdaq
  • KELYA Nasdaq
  • Market Cap
  • EOLS 787.7M
  • KELYA 752.3M
  • IPO Year
  • EOLS 2018
  • KELYA N/A
  • Fundamental
  • Price
  • EOLS $12.11
  • KELYA $14.44
  • Analyst Decision
  • EOLS Strong Buy
  • KELYA Buy
  • Analyst Count
  • EOLS 6
  • KELYA 1
  • Target Price
  • EOLS $22.60
  • KELYA $29.00
  • AVG Volume (30 Days)
  • EOLS 672.0K
  • KELYA 243.4K
  • Earning Date
  • EOLS 11-06-2024
  • KELYA 11-07-2024
  • Dividend Yield
  • EOLS N/A
  • KELYA 2.08%
  • EPS Growth
  • EOLS N/A
  • KELYA 80.11
  • EPS
  • EOLS N/A
  • KELYA 1.16
  • Revenue
  • EOLS $248,326,000.00
  • KELYA $4,372,900,000.00
  • Revenue This Year
  • EOLS $33.57
  • KELYA N/A
  • Revenue Next Year
  • EOLS $32.91
  • KELYA $8.90
  • P/E Ratio
  • EOLS N/A
  • KELYA $12.39
  • Revenue Growth
  • EOLS 34.42
  • KELYA N/A
  • 52 Week Low
  • EOLS $9.00
  • KELYA $14.37
  • 52 Week High
  • EOLS $17.82
  • KELYA $25.27
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 26.80
  • KELYA 25.49
  • Support Level
  • EOLS $16.12
  • KELYA $14.98
  • Resistance Level
  • EOLS $17.44
  • KELYA $22.44
  • Average True Range (ATR)
  • EOLS 0.75
  • KELYA 0.70
  • MACD
  • EOLS -0.48
  • KELYA -0.52
  • Stochastic Oscillator
  • EOLS 12.19
  • KELYA 0.37

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About KELYA Kelly Services Inc.

Kelly Services Inc is a provider of workforce solutions and consulting and staffing services. The company's operations are divided into five business segments namely Professional & Industrial, Science, Engineering & Technology, Education, Outsourcing & Consulting, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

Share on Social Networks: